Pulse Biosciences (PLSE) Gross Margin (2021 - 2025)

Pulse Biosciences' Gross Margin history runs 3 years deep, the most recent figure standing at 224.42% for Q3 2025.

• In Q3 2025, Gross Margin changed N/A year-over-year to 224.42%; the TTM figure through Sep 2025 stood at 224.42% (changed N/A YoY), while the FY2022 annual figure was 1606.29%, down 156750.0% from the prior year.
• Gross Margin was 224.42% for Q3 2025 at Pulse Biosciences, down from 14444.44% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 14444.44% in Q4 2022 to a low of 348.0% in Q2 2022.
• Historically, Gross Margin has averaged 2282.27% across 3 years, with a median of 75.88% in 2021.
• Biggest YoY gain for Gross Margin was 1449148 bps in 2022; the steepest drop was 1449148 bps in 2022.
• A 3-year view of Gross Margin shows it stood at 47.04% in 2021, then soared by 30808 bps to 14444.44% in 2022, then tumbled by 102 bps to 224.42% in 2025.
• The last three Gross Margin figures came in at 224.42% (Q3 2025), 14444.44% (Q4 2022), and 348.0% (Q2 2022), per Business Quant data.